Temporomandibular Joint Disorders
0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
City TherapeuticsMA - Cambridge
1 programType D Personality, Somatization and Perceived Social Support in Temporomandibular Joint DisordersN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2025
2026
City TherapeuticsType D Personality, Somatization and Perceived Social Support in Temporomandibular Joint Disorders
Clinical Trials (1)
NCT07292064City TherapeuticsType D Personality, Somatization and Perceived Social Support in Temporomandibular Joint Disorders
Type D Personality, Somatization and Perceived Social Support in Temporomandibular Joint Disorders
Start: Feb 2025Est. completion: Jun 2025
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space